Neutrolin Versus Heparin for Locking Hemodialysis Catheters
NCT ID: NCT03425448
Last Updated: 2019-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
192 participants
INTERVENTIONAL
2019-04-04
2021-04-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Neutrolin catheter locking agent comprises of heparin,citrate and trauolidine that had been studied in a prospective study in Germany, and it demonstrated a very good result in terms of reducing the catheter related infections and thrombosis.
This study is a multi-center, double-blind RCT comparing the hemodialysis catheter locking solution Neutrolin with heparin in reducing the rate of catheter related bacterial infection and thrombosis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Taurolidine in Haemodialysis Catheter Related Bacteraemia
NCT01243710
Efficacy and Safety of an Ethanol/Sodium Citrate Locking Solution: A Pilot Study
NCT01394458
Comparative Effectiveness of 30%TSC and Heparin Lock Solution in Hemodialysis Catheters
NCT02563041
Bicarbonate vs Heparin Catheter Lock in Chronic Hemodialysis Patients
NCT04054128
Addition of Heparin to Taurolock-TM CLS in HD Patients With TCC Dose it Improve Catheter Patency Problems ?
NCT00749619
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Heparin group
Heparin
Heparin hemodialysis catheter lock solution
Neotrolin Group
Neutrolin
Neutrolin hemodialysis catheter lock
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Heparin
Heparin hemodialysis catheter lock solution
Neutrolin
Neutrolin hemodialysis catheter lock
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject who will need chronic hemodialysis at least twice/week
* Subject likely to require for at least 120 days
* Subject or relative is likely to understand the nature of the study and sign the consent
* Age 18 years and older
Exclusion Criteria
* Subject with liver cirrhosis with encephalopathy
* Subject know to have allergy to heparin, citrate or traoulidine
* Documented history of arterial thrombosis or known to have hypercoagulable state
* Subjects with active skin infections and ulcers
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
King Abdullah International Medical Research Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Mubarak Al Abdalla
Consultant Nephrologist and Assistant Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC17/083/R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.